285 Works
Additional file 3 of Using a WeChat mini-program-based lactation consultant intervention to increase the consumption of mother’s own milk by preterm infants in the neonatal intensive care unit: a study protocol for a cluster randomized controlled trial
Jie Huo, Xinping Wu, Chuanli Gu, Zhangbin Yu, Jun Zhang, Xiaohui Chen, Jingai Zhu, Feng Liu, Beibei Liu, Qianqian Li & Shuping Han
Additional file 3.
Additional file 1 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 1: Figure 1. Overview of single-cell and prognostic value of each type cell’s biomarker in BLCA tissue. (A) The workflow of this study. (B) The t-SNE plot of all the single cells, with each color coded for 7 major cell clusters. (C) Differentiation trajectory of 7 cell clusters in BLCA. The violin plot of gene expression of RGS5 (D), KRT7 (E), and CD44 (F) in cluster0-6. (G) The bubble plot of gene expression...
Additional file 5 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 5: Figure 5. (A) Boxplot of expression of 14 checkpoints gene for low and high TS score groups in TCGA BLCA cohort. (B) Boxplot of 22 immune cells for low and high TS score groups in TCGA BLCA cohort. Wilcox test, *p < 0.05, **p < 0.01, ***p < 0.001. (C) TMB difference in the high and low TS score groups in TCGA BLCA cohort. Wilcoxon test, p = 0.36. (D) The correlation...
Additional file 6 of Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He & Wei Shen
Supplementary Material 6
Additional file 4 of Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He & Wei Shen
Supplementary Material 4
Additional file 3 of Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He & Wei Shen
Supplementary Material 3
Additional file 1 of Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He & Wei Shen
Supplementary Material 1
Additional file 1 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 1: Figure 1. Overview of single-cell and prognostic value of each type cell’s biomarker in BLCA tissue. (A) The workflow of this study. (B) The t-SNE plot of all the single cells, with each color coded for 7 major cell clusters. (C) Differentiation trajectory of 7 cell clusters in BLCA. The violin plot of gene expression of RGS5 (D), KRT7 (E), and CD44 (F) in cluster0-6. (G) The bubble plot of gene expression...
Additional file 6 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 6: Figure 6. The differential analysis of age (A), sex (B), pathological stage (C), T stage (D), M stage (E), N stage (F), race (G) between high and low TS score groups in TCGA BLCA cohort. Wilcox test: p (age) = 0.052, p (sex) = 0.059, p (pathological stage) < 0.001, p (T stage) < 0.001, p (M stage) < 0.001, p (N stage) = 0.061 and p (race) < 0.001. The ROC...
Additional file 7 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 7: Figure 7. Kaplan–Meier curves of OS for high and low TS score patients in 23 types of cancer. Log-rank test, p < 0.05.
Additional file 8 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 8: Figure 8. Kaplan–Meier curves of PFS for high and low TS score patients in 22 types of cancer. Log-rank test, p < 0.05.
Additional file 1 of Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
Xiaohui Wang, Wei Zhang, Yulin Guo, Yifei Zhang, Xiaofeng Bai & Yibin Xie
Additional file 1: Fig. S1. The LNM-DEGs associated with OS for STAD patients in TCGA Datasets based on uniCox (A) and multiCox (B) proportional hazard.
Additional file 2 of Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
Xiaohui Wang, Wei Zhang, Yulin Guo, Yifei Zhang, Xiaofeng Bai & Yibin Xie
Additional file 2: Fig. S2. qRT-PCR validation of 10-mRNA expression levels in gastric cancer cell lines (AGS and MGC-803) and normal cell lines (GES-1). ** indicates P < 0.01, and * indicates P < 0.05.
Additional file 1 of Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement
Yue-Peng Jiang, Song Wang, Wei-Dong Lai, Xue-Qing Wu, Yan Jin, Zheng-Hao Xu, Aubin Moutal, Rajesh Khanna, Ki Duk Park, Zhi-Ming Shan, Cheng-Ping Wen & Jie Yu
Additional file 1: Supplement Figure 1. Collagen treatment successfully induced RA. A. ELISA was used to detect antibodies to type II collagen (A) or CCP (B). * P < 0.05 vs. naive group, by unpaired and two-tailed Student’s t-test (n = 5 per group).
Additional file 18 of A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy
Dong He, Tao Xin, Bo Pang, Jun Sun, Zi Hao Liu, Zhen Qin, Xiao Shuai Ji, Fan Yang, Yan Bang Wei, Zi Xiao Wang, Jia Jia Gao, Qi Pang & Qian Liu
Additional file 18.
Additional file 20 of A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy
Dong He, Tao Xin, Bo Pang, Jun Sun, Zi Hao Liu, Zhen Qin, Xiao Shuai Ji, Fan Yang, Yan Bang Wei, Zi Xiao Wang, Jia Jia Gao, Qi Pang & Qian Liu
Additional file 20.
Additional file 2 of Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He & Wei Shen
Supplementary Material 2
Additional file 2 of Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer
Lin Yang, Shousheng Liu, Wenzhuo He, Zhenchong Xiong & Liangping Xia
Supplementary Material 2
Additional file 2 of Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu & Xianbin Zhang
Additional file 2: Supplementary figure 2. Landscape of the methylation levels of 5mC/m6A regulators across pan-cancer. (A, B) Correlations of methylation and mRNA expression of 5mC/m6A regulators. (C, D) Differential methylation of 5mC/m6A regulators between tumor and paired normal tissues in each cancer type. (E, F) Survival differences between high and low methylation of 5mC/m6A regulators in each cancer type, reflecting survival affected by methylation.
Additional file 5 of Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu & Xianbin Zhang
Additional file 5: Supplementary figure 5. Prognostic value of 5mC/m6A regulators. (A) Heatmap showing the univariate cox regression analysis of 5mC/m6A regulators with OS across pan-cancer. (B) Forest plot for the univariate cox regression analysis of 5mC/m6A regulators with HCC patients’ OS.
Additional file 7 of Crosstalk between 5-methylcytosine and N6-methyladenosine machinery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma
Yu Tian, Haijuan Xiao, Yanhui Yang, Pingping Zhang, Jiahui Yuan, Wei Zhang, Lijie Chen, Yibao Fan, Jinze Zhang, Huan Cheng, Tingwei Deng, Lin Yang, Weiwei Wang, Guoyong Chen, Peiqin Wang, Peng Gong, Xing Niu & Xianbin Zhang
Additional file 7: Supplementary figure 7. Subgroup analysis of HCC patients stratified by distinct clinicopathological factors. Kaplan-Meier curves of OS between high and low EME HCC patients in each subgroup of (A, B) age ≥65 and <65, (C, D) female and male, (E, F) G1-2 and G3-4, (G, H) stage I-II and stage III-IV, (I, J) T1-2 and T3-4, and (K, L) HBV infection and non-infection.
Additional file 9 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 9: Figure 9. Kaplan–Meier curves of DSS for high and low TS score patients in 21 types of cancer. Log-rank test, p < 0.05.
Additional file 10 of Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
Yanlong Zhang, Xin Zhang, Xuefeng Huang, Xiaomeng Tang, Menghan Zhang, Ziyi Li, Xiaopeng Hu, Min Zhang, Xi Wang & Yong Yan
Additional file 10: Figure 10. The wound filling assay (A), and cell viability (CCK-8) assay of T24 with or without TGF-β treatment (B). ANOVA analysis, p > 0.05.
Additional file 2 of ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, Hongwei Zhang, Yachong Liu, Furong Liu, Xiaoping Chen, Bixiang Zhang, Yan Chen & Peng Zhu
Additional file 2. PAQR4 promoted the migration and invasion of HCC cells in vitro (A–B).
Additional file 2 of ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner
Weijian Wang, Qibo Huang, Zhibin Liao, Hongwei Zhang, Yachong Liu, Furong Liu, Xiaoping Chen, Bixiang Zhang, Yan Chen & Peng Zhu
Additional file 2. PAQR4 promoted the migration and invasion of HCC cells in vitro (A–B).
Affiliations
-
ShenZhen People’s Hospital285
-
Shanghai Jiao Tong University250
-
Chinese Academy of Medical Sciences & Peking Union Medical College241
-
Fudan University237
-
Sichuan University235
-
Sun Yat-sen University231
-
Huazhong University of Science and Technology222
-
Capital Medical University212
-
Southern Medical University209
-
Peking University207